DBN1

DBN1 (Drebrin 1) is an actin-organizing protein that binds and bundles filamentous actin to shape cytoskeletal architecture in contexts ranging from sarcomeres to endocytic sites (PMID:26146072, PMID:31118234). In striated muscle, DBN1 alternates between myosin- and actin-rich regions over the contraction cycle, accumulating at I-bands to regulate the spacing of α-actinin and tropomyosin and to protect actin filaments from ADF/cofilin-mediated depolymerization, such that its loss leads to partial F-actin breakdown during contraction (PMID:26146072). At endocytic sites, DBN1 interacts with WIP-1 through the cortactin-binding domain of WIP-1, and its binding to F-actin is required to recruit Dynamin to promote scission of clathrin-coated pits (PMID:31118234). DBN1 protein levels are controlled by DNA-damage signaling: ATM-mediated phosphorylation of a β-TrCP1 degron containing an SQ motif targets DBN1 for SCFβ-TrCP1-dependent proteasomal degradation following DNA double-strand breaks (PMID:38097601). In cancer, DBN1 acts upstream of a GAB2–PI3K/AKT and MAPK/ERK signaling cascade to drive cell migration and invasion, and is itself suppressed by miR-218-5p binding its 3'-UTR (PMID:40910271); it also mediates adhesion of leukemia cells to bone marrow stromal cells via interaction with BAALC, contributing to chemoresistance (PMID:33453340).

1. 2014 Low

   Before functional dissection, it was unclear whether DBN1 associated with actin in a developmentally regulated manner in the nervous system; imaging during neural stem cell differentiation placed DBN1 at actin-rich neurites and dendritic spines.

   Evidence Immunohistochemistry, double-labeling immunofluorescence, and RT-PCR during NSC differentiation in mouse brain

   PMID:24814707

   Open questions at the time

   • No loss-of-function perturbation to establish causal role in differentiation
   • Co-localization alone does not demonstrate direct actin binding in this system
   • No molecular mechanism linking DBN1 to neurite outgrowth
2. 2015 High

   It was unknown how DBN1 acts on actin biochemically; reconstitution plus in vivo analysis established it as an actin bundler that protects filaments from cofilin-mediated depolymerization and organizes sarcomeric architecture.

   Evidence In vitro actin binding/bundling assays, live imaging and loss-of-function in C. elegans, co-localization with α-actinin, tropomyosin, ADF/cofilin

   PMID:26146072

   Open questions at the time

   • Demonstrated in C. elegans sarcomeres; conservation of the I-band role in mammalian muscle not directly tested here
   • Structural basis of the actin-protective bundling not resolved
3. 2019 Medium

   The role of DBN1 in membrane traffic was undefined; genetic and imaging work showed DBN1 F-actin binding is required to recruit Dynamin and drive clathrin-coated pit scission, linking it to WIP-1.

   Evidence Genetic screen, in vivo live imaging, loss-of-function, and interaction mapping in C. elegans intestine

   PMID:31118234

   Open questions at the time

   • Direct biochemical demonstration of DBN1-mediated Dynamin recruitment not reconstituted
   • Whether the WIP-1 interaction is conserved in mammalian endocytosis not addressed
4. 2020 Low

   Whether DBN1 contributes to tumor cell plasticity was open; a reported ITPKA-DBN1 interaction was linked to EMT in lung adenocarcinoma.

   Evidence Co-immunoprecipitation/pulldown and in vitro EMT functional assays in lung adenocarcinoma cells

   PMID:32015686

   Open questions at the time

   • Interaction method detail limited; not reciprocally validated
   • Molecular mechanism linking the interaction to EMT not defined
   • Single lab, single reported interaction
5. 2021 Medium

   The basis of DBN1's contribution to leukemia microenvironment anchoring was unknown; mass spectrometry identified BAALC as a partner and knockdown linked DBN1 to stromal adhesion and chemoresistance.

   Evidence Mass spectrometry interaction screen, DBN1 knockdown, cell adhesion and cytarabine sensitivity assays

   PMID:33453340

   Open questions at the time

   • Direct vs indirect nature of the BAALC-DBN1 interaction not established
   • Whether adhesion depends on DBN1 actin-bundling activity not tested
   • Single lab
6. 2023 High

   Regulation of DBN1 abundance was uncharacterized; biochemical reconstitution showed ATM phosphorylation of an SQ-containing β-TrCP1 degron triggers SCFβ-TrCP1-mediated proteasomal degradation after DNA double-strand breaks.

   Evidence UBIMAX mass spectrometry, proteasome inhibitor assays, degron mutagenesis, and reconstitution in Xenopus egg extracts

   PMID:38097601

   Open questions at the time

   • Functional consequence of DBN1 degradation for the DNA damage response not defined
   • Whether actin-related functions are coupled to this turnover not addressed
7. 2025 Medium

   How DBN1 promotes tumor invasion mechanistically was unresolved; knockdown plus RNA-seq and rescue placed DBN1 upstream of GAB2-driven PI3K/AKT and MAPK/ERK signaling, with miR-218-5p as an upstream repressor.

   Evidence Lentiviral knockdown, RNA-seq, western blot, Transwell/Matrigel invasion, GAB2 rescue, and dual-luciferase reporter in T-ALL cells

   PMID:40910271

   Open questions at the time

   • Mechanism by which DBN1 controls GAB2 expression not defined
   • Connection between DBN1 actin function and the signaling axis unclear
   • Single lab
8. 2025 Low

   DBN1's role in synaptic translation compartmentalization was unexplored; proximity labeling used DBN1 as a postsynaptic reporter and linked its downregulation to altered RNA granule protein proximity to IGF2BP1.

   Evidence Spatially-restricted biotinylation proximity labeling and DBN1 knockdown with RNA granule subproteome readout (preprint)

   PMID:bio_10.1101_2025.07.16.665171

   Open questions at the time

   • Preprint; mechanistic link is indirect (proximity changes as readout)
   • Direct DBN1 effect on local translation not demonstrated
   • Single lab, novel method not independently validated

• Whether DBN1's actin-bundling/anti-cofilin activity is the unifying mechanism beneath its endocytic, oncogenic-signaling, and synaptic roles, and how its DNA-damage-triggered turnover intersects these functions, remains unresolved.
• No study connects the actin function to the GAB2 signaling axis
• No structural model of DBN1-F-actin interaction in the corpus
• Functional purpose of DNA-damage-dependent DBN1 degradation undefined